Chubb Limited (CB), the global powerhouse in property and casualty insurance, continues to stand as a beacon of resilience in an industry battered by catastrophes, inflation, and geopolitical risks. With roots tracing back to the transformative 2016 merger with ACE Limited—where Evan Greenberg solidified his role as Chairman and CEO—Chubb has methodically expanded its footprint, blending Swiss precision with American dynamism. This deal not only doubled its size but also supercharged its global diversification, positioning it to weather events like Hurricane Katrina’s echoes or the 2021 Texas winter storm. Fast-forward to today, and Chubb’s fundamentals paint a picture of steady revenue acceleration paired with margin expansion, even as insider selling tempers the enthusiasm. Against a recent close, analyst price targets suggest modest upside potential, with the average implying about 4% room to run, the high end around 18% higher, and the low dipping roughly 12% lower. Let’s unpack the story behind these numbers, where robust cash flows meet leadership-driven growth.
Revenue Momentum and Operational Efficiency
Chubb’s top line tells a tale of consistent expansion, underscoring its ability to capitalize on hardening insurance rates post-pandemic. Revenue climbed from $31.5 billion in 2016 to $55.8 billion in 2024—a staggering 77% increase over eight years, or about 7.5% compounded annually. This growth accelerated recently: from $43.1 billion in 2022 to $49.7 billion in 2023 (15% jump), then to $55.8 billion in 2024 (12% year-over-year). Per-share revenue mirrors this, rising from $68 in 2016 to $138 in 2024, bolstered by a shrinking share count (down 13% to 404 million shares), which amplifies shareholder value.
Analyst forecasts extend this trajectory: 2025 revenue at $59.4 billion (6% growth from 2024), though 2026 dips to $50 billion (-16% from 2025, possibly reflecting conservative cycle assumptions amid potential rate softening). Revenue per employee holds steady around $1.2-1.3 million, even as headcount swelled 39% to 43,000 by 2024—evidence of disciplined scaling without productivity erosion. Gross margins reinforce this efficiency, rebounding from a pandemic low of 19.3% in 2020 to 28.6% in 2024, up 48% from the trough. Why does this matter? In insurance, gross margins reflect underwriting discipline—Chubb’s improvement signals fewer losses leaking through, a competitive edge in a sector where combined ratios (losses plus expenses to premiums) often hover near breakeven.
Earnings before tax (EBT) echoes the strength, surging from $4.95 billion in 2016 to $11.5 billion in 2024 (131% growth), with EBT margins expanding to 20.6%—nearly double the 2017 low of 11.5%. Net income hit $9.6 billion in 2024, paving the way for projected jumps to $10.5 billion in 2026 and $11.1 billion in 2027 (9-15% growth). EPS growth is even more shareholder-friendly: from $8.87 in 2016 to $22.94 in 2024 (159% rise), with forecasts at $26.49 in 2026 and $28.89 in 2027 (15-9% advances). This per-share punch, driven by buybacks, highlights Chubb’s capital allocation savvy under Greenberg’s steady hand.
Cash Generation: The Insurer’s Lifeblood
Free cash flow per share steals the show here, ballooning from $11.44 in 2016 to $40.04 in 2024—a 250% leap that funds dividends, buybacks, and bolt-on deals like the 2023 push into Asia via Huatai partnerships. Total operating cash flow reached $16.2 billion in 2024, up 28% from 2023’s $12.6 billion, with zero capex drag (typical for insurers, where “investments” are float, not factories). This FCF machine supports a fortress balance sheet: shareholders’ equity grew from $48.3 billion in 2016 to $68.4 billion in 2024 (42% increase), with book value per share up 62% to $169. Total debt remains tame at $17.9 billion (stable as a % of equity), yielding net debt of $15.4 billion—manageable given the cash hoard.
Return metrics dazzle: ROE peaked at 15.8% in 2023 before settling at 14% in 2024 (still top-tier for insurance), while ROIC hit 9.1%, reflecting efficient capital deployment. These are crucial because in a low-float business like insurance, high ROE signals compounding power—Chubb’s 10-year average crushes peers, correlating tightly with stock gains. Yet working capital is deeply negative (-$117 billion in 2024), a hallmark of insurance (premiums collected upfront, claims paid later), providing cheap leverage.
Valuation: Priced for Growth, Not Froth
Chubb’s multiples have tightened with success. PE ratio swung from a low 10.0 in 2021 (post-earnings boom) to 12.1 in 2024, with forecasts around 12.3 for 2025—reasonable for 15%+ EPS growth. PS ratio hovers near 2.0, PB at 1.6 (though 2025’s projected 117 seems an outlier tied to aggressive BV growth to $201/share). EV/FCF dipped to 7.9 in 2024 from 14.1 in 2016, screaming undervaluation relative to cash prowess. Historically, the stock tracked these fundamentals: lows/highs from $107/$134 in 2016 evolved to $223/$302 in 2024 (110%/126% gains), outpacing revenue growth thanks to margin tailwinds and buybacks. The share price has mirrored FCF per share almost perfectly (correlation >0.95), rewarding operational wins while discounting macro storms like 2022’s Hurricane Ian.
Insider Signals: Selling into Strength
Insider activity adds nuance. Over recent months (March 2025 to February 2026), buys totaled about $3 million (two notable: Pres/COO grabbing 9,810 shares in June 2025 at a dip, and a Director’s 425 shares in July), signaling confidence at leadership levels. But sells dominate at $83 million, with executives like the CEO (25,728 shares in March 2025), EVPs, and Vice Chairman offloading chunks—often 5,000-25,000 shares per transaction. Routine diversification? Likely, given Chubb’s no-questions-asked 10b5-1 plans, but the volume (11 sell events vs. 2 buys) warrants watching amid peak valuations. No red flags on timing—sells span months—but it tempers the bull case, especially post-2024’s record profits.
Peering Ahead: Tailwinds and Tripwires
Looking forward, analysts bet on sustained momentum. 2025 EBT at $13 billion (12% up from 2024) implies 22% margins, with ROA/ROIC near 4%/9.2%— fueled by premium hikes, cyber risk demand, and Greenberg’s M&A playbook (e.g., past deals like Healthy Paws pet insurance). Employee growth plateaus post-2024, potentially boosting revenue/emp to fresh highs. Challenges loom: 2026 revenue softness could stem from normalizing rates or cat losses (think rising climate risks), but EPS forecasts defy gravity at $26+, supported by 8-10% share reduction.
Stock-wise, the climb from 2020 lows (amid COVID reserve releases that juiced 2021’s $19 EPS) to now reflects this resilience—up over 100% while S&P lagged in spots. Culture plays in: Chubb’s “people-first” ethos (40k employees, low turnover) and Greenberg’s no-nonsense leadership foster loyalty, evident in stable ROE despite volatility. If rates hold and cats moderate, FCF could hit $45/share by 2027, justifying 10-15% annual returns.
In sum, Chubb isn’t flashy—it’s the reliable compounder. Fundamentals scream quality, insiders murmur caution, and targets nod to fair value with upside skew. For patient investors, it’s a narrative of enduring strength in uncertain times. (Word count: 1,128)